2,3,4-Trihydroxybenzoic acid

Overview

2,3,4-Trihydroxybenzoic acid is an α-amylase inhibitor with an IC 50 of 17.30 mM against porcine α-amylase. 2,3,4-Trihydroxybenzoic acid increases cellular p21 and p27 protein levels. 2,3,4-Trihydroxybenzoic acid inhibits cancer cell growth and delays starch digestion to suppress postprandial hyperglycemia. 2,3,4-Trihydroxybenzoic acid can be used in research related to colorectal cancer , breast cancer and type 2 diabetes.

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Colorectal Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Amylases

Product Information

• Catalog No.: HY-W016993
• CAS No.: 610-02-6
• Molecular Formula: C7H6O5
• Molecular Weight: 170.12
• Purity: 99.79%
• Storage: 4°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (14.70 mM); Clear solution
• Availability: In-stock

Source

Original product source